Pregled bibliografske jedinice broj: 1234855
A new challenge for control selection in influenza vaccine effectiveness test-negative design studies in the COVID-19 context:Results from European I- MOVE multicentre study at primary care level
A new challenge for control selection in influenza vaccine effectiveness test-negative design studies in the COVID-19 context:Results from European I- MOVE multicentre study at primary care level // Abstract book: ESCAIDE 2022 European Scientific Conference on Applied Infectious Epidemiology / Catchpole, Mike (ur.).
Stockholm: ECDC, 2022. str. 54-55 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1234855 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A new challenge for control selection in influenza
vaccine effectiveness test-negative design studies
in the COVID-19 context:Results from European I-
MOVE multicentre study at primary care level
Autori
Kissling, Esther ; Martinez-Baz, Ivan, Buda, Silke, Mazgatos, Clara ; Višekruna Vučina, Vesna ; Nonković, Diana ; et al.
Kolaboracija
I-MOVE-COVID-19 and ECDC primary care study team
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstract book: ESCAIDE 2022 European Scientific Conference on Applied Infectious Epidemiology
/ Catchpole, Mike - Stockholm : ECDC, 2022, 54-55
ISBN
978-953-7124-12-0
Skup
European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE 2022)
Mjesto i datum
Stockholm, Švedska, 23.11.2022. - 25.11.2022
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
COVID-19 ; vaccination ; influenza ; case-control studies ; multicentre study
Sažetak
31% of controls were positive for SARS-CoV-2, exluding them increased IVE estimation by <10% overall. and only 3% in the vaccination target group.
Izvorni jezik
Engleski
